Stocks · Health care · Pharmaceutical Preparations

Acrivon Therapeutics, Inc.

ACRV Clue Score43
United States Fiscal year ends December CIK 0001781174 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Eric Devroe
17 May 2024
Chief Operating Officer
Exercised, kept
10,000
$1.04
$10.40K
Rasmus Holm-Jorgensen
16 Jun 2023
Chief Financial Officer
Exercised, kept
9,500
$3.63
$34.49K
Eric Devroe
5 Jun 2023
Chief Operating Officer
Exercised, kept
9,225
$1.04
$9.59K
Peter Blume-Jensen
31 May 2023
President and CEO
Exercised, kept
33,605
$3.88
$130.39K

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 37
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 18,397,067
History held since 16 Nov 2022